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Aberrant Lymphatic Drainage of Primary Invasive Lobular 
Carcinoma with Concurrent Primary Lung Adenocarcinoma: A 
Case Report 
Rina Won Lee,1 Emily Denney.1 
Abstract 
Background: Lymphatic spread of breast cancer is currently well understood and can be assessed in breast cancer patients through the use of lymphatic 
mapping with sentinel node biopsy, computed tomography or positron emission tomography. However, this case highlights a unique pattern of lymphatic 
spread of unknown etiology. The Case: A 73-year-old female with two distinct primary carcinomas, right-sided invasive lobular carcinoma of the breast 
and left-sided adenocarcinoma of the lung. We discuss the predictable and unpredictable lymphatic drainage of the lobular carcinoma, including ipsilateral 
drainage to the axillary chain and suspected contralateral hilar and mediastinal lymph node metastasis. Conclusion: The unique lymphatic spread of the 
breast cancer in this case emphasizes the use of lymphatic mapping for staging of disease and staining biopsied tissue samples for tumor markers to 
guide treatment. Additional anatomic research in this patient or supporting reported cases are needed to determine the frequency and cause of aberrant 
lymphatic drainage of primary invasive lobular carcinoma of the breast. 
 




Invasive lobular carcinoma (ILC) comprises approximately 10% of all 
breast cancers.1 The malignant cells line up in a single file in the stroma 
and usually do not form a distinct, palpable mass. Overall, the 
prognosis tends to be good, due to the low grade of the tumor and its 
nature of being estrogen receptor positive (ER +).2 However, ILC tends 
to be multifocal and multicentric and can involve both breasts.3 Such 
characteristics have led to cases of distant metastases involving the 
peritoneum, ovaries, and uterus.4 The vast majority of breast 
malignancies tend to spread via axillary lymph nodes, but there can 
also be nodal metastases outside of the axillary lymph nodes, involving 
the internal mammary, infraclavicular, and supraclavicular lymph 
nodes.5 Furthermore, breast malignancies, using lymphatic and 
hematogenous routes, can have pulmonary involvement, called 
pulmonary lymphangitic carcinomatosis.6 
 
Adenocarcinoma of the lung is the most common type of lung cancer 
and can quickly spread to distant sites via lymphatic and 
hematogenous routes, which often results in stage IV disease by the 
time of patient presentation.7 
 
Here, we present an interesting case of a primary, right-sided invasive 
lobular carcinoma with ipsilateral axillary nodal involvement and 
primary, left-sided adenocarcinoma of the lung with suspected 
ipsilateral hilar and mediastinal lymph node metastasis, which actually 
turned out to be invasive lobular carcinoma. Informed consent of 




The patient is a 73-year-old African American female with no family 
history of breast or ovarian cancer who initially presented due to a right  
 
breast mass palpated upon routine self-breast examination. She had a 
screening mammogram completed, which showed a 2.5cm spiculated 
mass in the right breast at the 6 o’clock position, 16cm from the nipple 
along with a 1.1cm asymmetry anterior to the mass and a 0.8cm 
asymmetry in the right retroareolar region (Figure 1). The radiologist 
assessment was BI-RADS 0 (Breast Imaging Reporting and Database 
System), and additional imaging was recommended.  
 
Two weeks later, the following diagnostic mammogram showed a 2.3cm 
irregular, spiculated mass in the right breast at the 9 o’clock position, 
17cm from the nipple along with a 0.7cm mass, 2cm from the nipple. 
Whole breast ultrasound showed a solid mass in the right 8 to 9 o’clock 
position, highly suspicious for malignancy along with an abnormal 
lymph node in the right axilla. The radiologist assessment this time was 
BI-RADS 5: highly suggestive of malignancy, so biopsies of the lesion 
and lymph node were recommended. 
 
The patient was seen by a breast surgeon, who examined the patient 
and noted the patient’s breasts to be enormous and very pendulous 
with palpation of some nodularity in the  extreme  outer  right  breast,  
Highlights: 
 This is a case report of a patient, with no known genetic 
abnormalities, who was found to have two primary carcinomas, 
invasive lobular carcinoma and adenocarcinoma of the lung, after 
workup of a breast mass found during self-examination. 
 The lymphatic drainage of the invasive lobular carcinoma was found 
to be atypical, spreading to the contralateral lymphatic beds without 
involvement of the ipsilateral lymphatic beds. 
 Furthermore, the case points to the use of imaging techniques in the 
diagnosis and treatment of cancers. 
Case Report  
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Figure 2: Ultrasound Image Showing Right Breast Mass Prior to Biopsy. 
 
 
but no lymph nodes were palpated in the axillary and supraclavicular 
regions. 
 
The following day, patient underwent an ultrasound-guided core biopsy 
with multiple cores taken from the primary lesion in the right breast at 
the 8 o’clock position, 13cm from the nipple (Figure 2). The 5-6mm 
satellite lesion was seen 3-4mm away from the primary lesion, but no 
biopsy samples were taken. Multiple cores were taken from an enlarged 
right axillary lymph node, which showed cortical thickening with 
compromise of the hilum that measured 1cm. The pathology report that 
followed showed invasive lobular carcinoma with positive axillary 
metastasis. 






Figure 4. PET Image Showing Fluorodeoxyglucose Uptake in Superior 




Breast-specific gamma imaging (BSGI) and Positron emission 
tomography-computed tomography (PET-CT) were ordered one week 
later. The BSGI showed a 2cm diameter area of intense focal uptake in 
the right breast at 9 o’clock, 15cm from the nipple with no evidence of 
multifocal, multicentric disease. The PET-CT findings included: an 
irregular right lateral breast mass, consistent with known right breast 
carcinoma, mildly enlarged right axillary lymph nodes consistent with 
nodal metastases (Figure 3), and an irregular nodule within the superior 
segment of the left lower lobe, which was concerning for metastasis or 
concurrent primary bronchogenic carcinoma (Figure 4). 
 
Based on such findings, the breast surgeon and interventional 
radiologist agreed upon a CT-guided biopsy of the left pulmonary lesion 
(Figure 5) 2 weeks after the imaging studies were completed. Two 20-
gauge core biopsy specimens were obtained with no complications, and 
the pathologist reported well differentiated pulmonary adenocarcinoma 
with predominant lepidic growth pattern. The specimens stained 
positively for cytokeratin 7, napsin-A, and TTF-1 (thyroid transcription 
factor-1). The major risk factor for the patient was a history of tobacco 
use, which started at 17 years of age.  
 
At this point, the patient’s diagnoses were stage II carcinoma of the 
breast and a primary tumor of the left lung. Three weeks later, the 
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Figure 5. CT showing left lung lesion prior to biopsy 
 
 
and axillary dissection. The pathology report confirmed invasive lobular 
carcinoma, and 2/2 lymph nodes tested positive for metastatic lobular 
carcinoma. The tumor was ER (estrogen receptor) positive, PR 
(progesterone receptor) negative, and HER2 (human epidermal growth 
factor receptor 2) negative. The staging of the breast cancer was T1c N1 
M0 stage IIa invasive lobular carcinoma. 
 
The patient was referred to an oncologist and cardiothoracic surgeon. 
One month later, she had a left lower lobectomy and mediastinal lymph 
node dissection performed. An 18.5 x 12.0 x 4.0cm lobe of the left lung 
that weighed 173.4g was removed. The pathology report showed 
moderately differentiated adenocarcinoma with lepidic predominance; 
all the vascular and bronchial margins were free of tumor. However, 
the pathology report showed the left mediastinal lymph nodes to 
actually be invasive lobular carcinoma: 1 of 1 peribronchial, 5 of 6 
interbronchial, 1 of 1 subcarinal, 1 of 1 aortopulmonary window, 1 of 1 
left inferior pulmonary ligament, and 1 of 1 hilar. The hilar lymph nodes 
stained positive for pankeratin and GATA3 (transcription factor and 
breast cancer marker) (Takaku) and negative for TTF-1 (Schilsky) and 
CD68. They were strongly positive for ER 100%, positive for PR 2%, and 
HER2 negative. Based on such histological characteristics, the left hilar 
lymph nodes were most consistent with metastatic invasive lobular 
carcinoma and not lung adenocarcinoma. The patient’s diagnoses were 
changed to stage IV carcinoma of the breast and stage IA2 (T1b, N0, 
M0) carcinoma of the lung. She is currently undergoing chemotherapy 
with letrozole and Ibrance (palbociclib). 
 
Discussion 
Here we presented a unique case of primary lobular carcinoma of the 
right breast, primary invasive adenocarcinoma of the left lower lung 
lobe with pankeratin positive, GATA3 positive, ER positive left 
peribronchial lymph node involvement. Lymphatic spread of breast 
cancer is thought to be well understood. This case highlights a unique 
pattern of lymphatic spread of unknown etiology. Review of other case 
reports indicates the pattern of lymph node involvement in this patient 
with invasive lobular carcinoma of the breast is quite unique. While 
other cases were found on spread of invasive lobular carcinoma to the 
contralateral breast and aberrant lymphatic drainage patterns in 
recurrent breast cancer after treatment, no additional cases were found 
in the literature of spread of invasive lobular carcinoma to contralateral 
hilar and mediastinal lymph nodes in a patient with no previous history 
or treatment of breast cancer. 
 
Lymphatic drainage of the breast drains ipsilaterally through the 
axillary, transpectoral and internal mammary pathways.8 Further 
drainage occurs into “lymphatics that course along the axillary and 
contiguous subclavian vein. From here, the lymphatics may drain 
directly into the jugulosubclavian confluence or initially pass through 
the jugular and bronchomediastinal lymphatics.”8 The variance of 
lymphatic drainage seen in various tumors may be attributed to the 
quality of the lesions, whether it is palpable or nonpalpable, and the 
location of the lesion within the breast, either in the right outer, right 
inner, left outer, or left inner quadrant or in the center. According to 
Estourgie et al, both palpable and nonpalpable lesions can drain toward 
the internal mammary chain, but this pattern is more commonly seen 
with nonpalpable lesions.9 Furthermore, Estourgie et al. reveal 97.1% of 
palpable lesions in the left outer quadrant should be expected to drain 
to the axillary lymphatic bed while 26.1% of palpable lesions in the 
same location drained to the internal mammary chain of lymphatics.9 
Because of the location of the primary breast tumor in the left outer 
quadrant (9 o’clock position of the right breast), the most predictable 
pattern of lymphatic drainage in this patient would be to the axillary 
nodes. While this patient had involved lymph nodes in the axillary 
chain, including sentinel nodes, stain positive for the invasive lobular 
carcinoma, additional lymphatic drainage to the contralateral hilar and 
mediastinal lymph nodes without ipsilateral hilar and mediastinal 
lymph node involvement was unique and not currently explained by 
the literature. 
 
The question raised by the physicians caring for this patient was, how 
did the breast cancer spread to a single, contralateral region of lymph 
nodes without involvement of other ipsilateral or contralateral lymph 
node beds? Could this be an anatomic variant in this patient? Were 
there additional factors that allowed the spread of the tumor to a 
contralateral lymphatic bed, or was the cancer undiagnosed for a length 
of time adequate enough for the lobular carcinoma to contralaterally 
spread? According to Sharma et al.,8 obstruction of normal lymphatic 
flow allows for development of collateral lymphatic drainage pathways, 
including internal mammary and mediastinal lymphatics. Lymphatic 
mapping with sentinel node identification in this patient identified 
drainage of the primary tumor to the axillary nodes. An anatomical 
variant or development of collateral pathways not assessed during the 
lymphatic mapping could explain the unique spread of the invasive 
lobular carcinoma in this patient. This case may support the expansion 
of lymphatic mapping into further lymphatic regions to identify spread 
of the tumor and may prompt further developments and advancements 
in lymphatic mapping as it pertains to breast cancer. The unpredictable 
lymphatic spread in this case prompts the discussion of the 
appropriateness of routine PET scans prior to treatment in breast cancer 
patients with no evidence of additional lymphatic spread on CT. CT is 
commonly used in cancer imaging to determine lymph node 
involvement. Because involved lymph nodes appear normal on CT, 
fluorine-18 fluorodeoxyglucose (FDG) PET can be used for more accurate 
detection of lymphatic spread of the primary tumor and relevant lymph 
node involvement.8 Additional reports and studies are needed to 
determine the incidence of contralateral spread of lobular carcinoma of 
the breast to unusual lymphatic beds to determine the benefit of FDG-
PET in conjunction with current CT scanning on patients with suspected 
additional extra-axial or contralateral lymph node involvement. 
 
During the initial assessment of the patient, the involved hilar and 
mediastinal lymph node was suspected to be secondary to the primary 
adenocarcinoma of the left lung by the treatment team. Only through 
further staining and discussion was the origin of the carcinoma in the 
hilar and mediastinal lymph nodes discovered. 
 
The complexity of this case illustrates the importance of staining 
biopsied tissue samples for tumor markers to accurately stage the 
disease and to ensure a chemotherapy regimen and further treatment 
is appropriate. Further research is needed to determine the impact of 
the aberrant lymphatic drainage of primary invasive lobular carcinoma 
as seen in this patient. 
Case Report  
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